心脉隆注射液药理作用和治疗心力衰竭临床观察

The pharmacological action of Xin mailong and the clinical effect of adjuvant therapy of heart-failure

目的:探讨心脉隆注射液的药理作用和辅助治疗心力衰竭的临床效果。方法:92例患者作为研究对象,随机分为实验组和对照组,两组均给予常规治疗,实验组加用心脉隆注射液辅助治疗。结果:①实验组BMI、HDL-C、FBG和2hFBG等指标改善程度大于对照组,但无显著性差异(P>0.05);TG和Homa-IR改善程度则显著优于对照组。②实验组LVEF、LVED和LVESD等指标均显著优于对照组。结论:心脉隆注射液辅助治疗心力衰竭患者,可显著提高治疗效果,改善心室重构,值得临床考虑。

Objective：To explore the pharmacological action of Xin mailong and the clinical effect of adjuvant therapy of heart-failure. Methods：92 cases of patients as studied object were randomly divided into experimental group and control group. Both groups were given routine therapy, and experimental group were added with adjuvant therapy of Xin mailong. Results： （1）The improving degree of BMI.HDL-C.FBG and 2hFBG in experimental group were bigger than in control group, but no significant difference （P〉0.05）, but TG and Homa-IR in experimental group improved significatly better. （2） LVEF.LVED and LVESD in experimental group were significantly better than that in control group. Conclusion： Adjuvant therapy of Xin mailong used for patients with heart-failure,can enhance clinical effect significantly and improve the ventricular remodeling, it deserved considering in clinical work.